M Bagger Scientific Writing ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  14.2% 17.3% 10.4% 13.6% 21.3%  
Credit score (0-100)  16 9 22 16 4  
Credit rating  BB BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  333 0 0 0 0  
Gross profit  323 281 487 454 412  
EBITDA  135 76.1 210 64.0 133  
EBIT  135 76.1 210 64.0 133  
Pre-tax profit (PTP)  134.9 74.9 209.1 61.3 132.9  
Net earnings  105.2 57.1 163.1 51.5 103.7  
Pre-tax profit without non-rec. items  135 74.9 209 61.3 133  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  161 118 214 151 155  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  281 223 369 246 196  

Net Debt  -281 -223 -369 -246 -196  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  333 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  323 281 487 454 412  
Gross profit growth  0.0% -13.1% 73.5% -6.8% -9.4%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  281 223 369 246 196  
Balance sheet change%  0.0% -20.8% 65.5% -33.2% -20.5%  
Added value  135.1 76.1 210.3 64.0 133.1  
Added value %  40.5% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  40.5% 0.0% 0.0% 0.0% 0.0%  
EBIT %  40.5% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  41.8% 27.1% 43.1% 14.1% 32.3%  
Net Earnings %  31.6% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  31.6% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  40.5% 0.0% 0.0% 0.0% 0.0%  
ROA %  48.0% 30.2% 71.1% 20.8% 60.2%  
ROI %  84.0% 54.6% 126.7% 35.1% 87.2%  
ROE %  65.4% 41.0% 98.3% 28.2% 67.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  57.1% 52.9% 58.0% 61.3% 79.0%  
Relative indebtedness %  36.2% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  -48.2% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -208.3% -292.8% -175.4% -385.1% -147.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.3 2.1 2.4 2.6 4.8  
Current Ratio  2.3 2.1 2.4 2.6 4.8  
Cash and cash equivalent  281.4 222.8 368.9 246.4 195.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  84.4% 0.0% 0.0% 0.0% 0.0%  
Net working capital  160.8 117.8 213.9 151.0 154.7  
Net working capital %  48.2% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  333 0 0 0 0  
Added value / employee  135 76 210 64 133  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  135 76 210 64 133  
EBIT / employee  135 76 210 64 133  
Net earnings / employee  105 57 163 51 104